Lifestyle

Most rising professionals avoid making financial decisions because they lack good information or professional help.

The roller coaster isn't over for the diabetes drug maker's stock, which first shot up in March over news that Bristol had placed a bid. But is the stock now overweight?

Even now people are still experiencing the fallout from using 419 plans years ago. And the lessons seems to be that if a structure sounds too good to be true, it just might be.

There are apparent trends related to the election cycle that we might factor in to our financial decisions that could give some mild relief. Or add to our confusion, depending upon your point of view.

Despite the expectation that health care spending growth would increase in 2012, it has not. In fact, it's also expected to remain slow in 2013.

Seller beware: In China, if someone successfully bids for art at auction there is an almost 50/50 chance of non-payment.

After a failed midstage trial for a rheumatoid arthritis drug, Chelsea Therapeutics announced it ended studies on the drug causing the company's stock to plummet 33%.

What are the trends and motivating factors for both hospitals and physicians?

To give you the most options and choices at retirement you should consider stashing your nest egg away in both pre- and post-tax accounts.

Brno, the second largest city in the Czech Republic, may be an enigma to Americans, but it's less expensive, busy and touristy than Prague. And you can walk through its very heart in a single day.

Patients who took Lundbeck's experimental Alzheimer's drug achieved significant improvement in cognition, according to trial data from the Danish drugmaker.

With as much pessimism as the younger generation of doctors is experiencing, we're headed for widespread physician unhappiness, if not burnout!

Earning a little money by working during your vacation may seem easy enough, but deducting business expenses on these working vacations can be tricky.

While mobile devices make it easier for doctors and health care organizations, it places a higher priority on securing networks containing medical information from malicious attacks.

Ever since Teva Pharmaceuticals released its mixed first quarter earnings report, the company's shares have been on a four-week fall. But there are plenty of brokers still bullish about the stock.

Medical practice inefficiency is a widespread problem and many medical practices are unable to implement efficiency changes because they are often economically strapped.

More are considering alternatively fueled vehicles because the cost of gas is getting so high, according to a Consumer Reports survey.

You've probably heard that risk and return go hand in hand, that you have to take more risk to get better returns. But there are exceptions. Low volatility stocks are one of them. Historically, they have performed as well as the broad market with far less risk.

Tired of watching the stock market go up and down? Time to consider investing in an asset with room to run: senior assisted living facilities.

Smaller practices have been leading the way toward e-prescription adoption, and the largest year-over-year growth happened among solo practitioners.

The New York City Frieze Art Fair has everything from the quirky to the usual, the traditional to the experimental, including work by Chinese dissident Ai Weiwei.

Although oncologists felt left on the sidelines in regards to Accountable Care Organizations, a private insurer and a health system are teaming up to create the first cancer-specific ACO.

The summer is right around the corner and with it people will be flocking to the beach. But just what type of getaway are you looking for?

The team physician in Minnesota knew he wanted a practice where the support staff truly supported him when he opened Crutchfield Dermatology.

Unhappy investors in Facebook might get some satisfaction. Regulators have turned their eye on the social networking company as well as lead underwriter Morgan Stanley for the messy stock debut on Friday, May 18.

Decisions on drug approvals can be big news for a company, but it's the investors who get in beforehand who really make out great.

Despite failing to meet its primary endpoint of improving the overall survival rate of patients with non-small cell lung cancer, it wasn't all bad news for Onyx Pharmaceuticals.

How much productive time do you lose reaching out to a referring physician and waiting to hear back? What if you were able to access the intelligence and years of experience of a group of physicians, with a few taps on your mobile?